Adenoviral vectors containing the CTLA4IG-gene inhibit chronic rejection in heterotopically transplanted rat tracheas.
Kita
Y
Y
First Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Li
X K
XK
Ohba
M
M
Funeshima
N
N
Enosawa
S
S
Nogimura
H
H
Ohi
S
S
Kageyama
Y
Y
Matsushita
K
K
Ito
Y
Y
Takahashi
T
T
Suzuki
K
K
Suzuki
S
S
Kazui
T
T
D000069594:Abatacept; D000256:Adenoviridae; D000818:Animals; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000235:genetics* / Q000627:therapeutic use; D060908:CTLA-4 Antigen; D002908:Chronic Disease; D015316:Genetic Therapy / Q000379:methods; D005822:Genetic Vectors; D006084:Graft Rejection / Q000276:immunology / Q000473:pathology / Q000517:prevention & control*; D006085:Graft Survival / Q000276:immunology; D018796:Immunoconjugates; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents; D008297:Male; D051381:Rats; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains; D013997:Time Factors; D014132:Trachea / Q000473:pathology / Q000637:transplantation*; D016042:Transplantation, Heterotopic; D014184:Transplantation, Homologous / Q000276:immunology* / Q000473:pathology
D015703:Antigens, CD; D000943:Antigens, Differentiation; D060908:CTLA-4 Antigen; C556708:Ctla4 protein, rat; D018796:Immunoconjugates; D007166:Immunosuppressive Agents; D000069594:Abatacept